TROG Cancer Research
Members Login   CQMS Login

TD 17.07 (SKAGEN Trial 1)

Primary Sponsor: Danish Breast Cancer Cooperative Group (DBCG)
Collaborative groups: Trans Tasman Radiation Oncology Group (TROG)


Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost


This study aims to investigate the difference in late radiation morbidity between hypofractionated and normofractionated loco-regional breast irradiation irrespective of mastectomy or lumpectomy. In patients who a candidates for a boost, the boost will be provided as a simultaneous integrated boost

Opening to recruitment

Approximately Quarter 2, 2018

Trial chairperson

Dr Kirsty Stuart, Crown Princess Mary Cancer Centre, Westmead

Trial contact

Rebecca Montgomery
Clinical Trials Project Manager
TROG Trial Coordinating Centre
Phone: +61 2 4014 3910

Trial resources for TROG members

TD 17.07 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.